News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Thursday, July 31, 2014

Top Breaking News
Menlo Park's Avalanche Biotechnologies (AAVL) Rolls Onto Nasdaq, Raises $102 Million For Its IPO
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Bags BioMarin Pharmaceutical Inc. (BMRN)'s Special FDA Priority Review Voucher For $67.5 Million
Novartis AG (NVS) Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner
Flailing Dendreon Corporation (DNDN) Brings In Ex-Johnson & Johnson (JNJ) Exec For Top CEO Post
AstraZeneca PLC (AZN) Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK), And Roche (RHHBY)
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse
FDA Panel Reviews Safety Of Baxter International, Inc. (BAX)'s Experimental Drug For Immune System Disorders
Cambridge-Based Gen9 Gets $25 Million In Equity Funding For DNA Synthesis
Sanofi (France) (SAN.PA) Second Quarter Profit Jumps 73 Percent; Earnings Outlook Lifted
SoCal Biopharma Cold Genesys, Inc. Locks In $13.57 Million Series A
Catalent Pharma Solutions (CTLT) Prices IPO At Midpoint Range, Raises $871 Million
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share
Israeli Biotech Macrocure Sets Terms for $75 Million IPO
50 Jobs Promised As Stem Cell Company Precious Cells BioBank Gets Bigger
FDA Concern Over Drug Production Process At India's Cadila
CytoDyn Announces Positive Interim Results From Its Treatment Substitution Study in Patients With HIV

Featured Stories
Puma Biotechnology (PBYI)'s Overnight Billionaire On One Of His Keys To Success
Insiders Reveal That Valeant Pharmaceuticals International (VRX)'s Cost Cutting May Have Gone Too Far
Gilead Sciences, Inc. (GILD) Popular Amongst Latest 13F Filers
Common Pesticide Linked To Slow Metabolism, Obesity, And Diabetes, University of California, Davis (UCD) Study
Light Shed On How Depression Is Related To Dementia, Rush University Medical Center Study
Tree Nuts May Fight Metabolic Disease, Diabetes, St. Michael's Hospital Study
Psychologists Discover A Surprising Thing Happens To Kids Who Read Harry Potter, University of Modena Reveals
Soy May Help Women's Hearts If They Start Early, Wake Forest University School of Medicine Study
You Make 5-10 Ounces Of Tears A Day, And There Are 3 Types, University of California, Berkeley (CAL) Reveals

More News
Expanded Data On Disability And Cognitive Improvements In Phase 2 Study Of Synthetic Biologics, Inc. (SYN)' Trimesta™ In Multiple Sclerosis To Be Presented At 2014 Joint ACTRIMS-ECTRIMS Meeting
NOXXON Pharma AG Initiates Phase IIa Study Of Anti-Hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) In Dialysis Patients With EPO-hyporesponsive Anemia
ESTEVE Announces The Start Of A Natural History Study In Patients With Sanfilippo Syndrome Type A (MPSIIIA)
The Rendon Center for Dermatology and Aesthetic Medicine Release: Indoor And Outdoor Sun Tanning Or Sun Burns Directly Linked To Deadly Melanoma Skin Cancer
ChromaDex, Inc. Signs Material Transfer Agreement With Prominent Australian Research Institute For NIAGEN™ Research
Columbia Laboratories, Inc. (CBRX)' Subsidiary, Molecular Profiles, Strikes Alliance With Molecular Profiles
Catylix, Inc. And Aspira Scientific Announce Joint Venture To Commercialize New Fluorination Technologies
Catylix, Inc. And Aspira Scientific Announce Joint Venture To Commercialize New Fluorination Technologies
PuraMed BioScience Rebrands Its Natural Migraine Relief Medication, Lipigesic M
Innocoll, Inc. Announces Closing Of Initial Public Offering
VBL Therapeutics Announces Pricing Of Initial Public Offering
Bio Blast Pharma Prices Initial Public Offering Of $35,200,000 Of Ordinary Shares
China Cord Blood Corporation Files Its Annual Report On Form 20-F
CytoDyn Announces Investment Community Call To Discuss Interim Results From Its Treatment Substitution Study In Patients With HIV
Walgreens Named Exclusive Specialty Pharmacy Provider For Sigma-Tau Pharmaceuticals’s, Prescription Drugs: Adagen®, Cystaran Adagen® and Matulane Adagen®
Israel's Ministry Of Health Approves Pluristem Therapeutics (PSTI)'s Commercial-Scale 3D Cell Manufacturing Process Used At Its New Haifa Facility
Zealand Pharma  (ZEAL.CO) Reports Increased Lyxumia® Royalty Revenue For H1 2014 And Informs Of Status Update As Provided By Sanofi
Cannabis Science Inc. Initiates Scientific Cultivation Programs To Test Multiple Strains Of Cannabis To Obtain Extract Formulations For Clinical Drug Development Targeting Multiple Critical Ailments Starting With Cancer And Neurological Disorders
Unilife Corporation (UNIS) Accelerates Investment To Meet Increasing Demand From New And Existing Customers
Weill Cornell Medical College Selects OpenTempo Workforce Optimization Solution
Marken (Formerly known as Marken Time Critical) Expands Miami Regional Logistics Center
iMedicor Launches Proprietary iCoreMD, Cloud-Based, Customizable Electronic Health Records Platform
BioLife Solutions, Inc. (BLFS.OB) To Report Financial Results For Second Quarter 2014 And Provide Business Update On August 7, 2014
Becton, Dickinson and Company (BDX) Announces Results For 2014 Third Fiscal Quarter
DURECT Corporation (DRRX) Invites You To Join Its Second Quarter 2014 Earnings Conference Call
Endo International plc (ENDP) Appoints Shane M. Cooke To Board Of Directors
Endo Pharmaceuticals (ENDP) Reports Second Quarter Financial Results
MediWound (MDWD) Reports Second Quarter 2014 Financial Results
Nuvo Research Inc. (NRI.TO) Announces 2014 Second Quarter Results
Pharming Group (PHGUF.PK) Reports On Financial Results First Half Year 2014
Regulus Therapeutics, Inc. Announces Timing For Second Quarter 2014 Financial Results Webcast And Conference Call
Synageva BioPharma (GEVA) Reports Second Quarter 2014 Financial Results
Sanofi (France) (SAN.PA) H1 2014 Results - Interview With Chris Viehbacher
Vical Incorporated (VICL) Reports Second Quarter 2014 Financial Results And Progress In Key Development Programs
Valeant Pharmaceuticals International (VRX) Reports Second Quarter 2014 Financial Results
Chicago Bears Join The American Academy of Dermatology In Fight Against Skin Cancer
JDRF Commends Senators Collins And Shaheen For Introducing Legislation To Ensure Seniors With Diabetes Have Access To Continuous Glucose Monitors
Institute For Supply Management, Michigan State University To Recognize Companies With Excellent Supply Management Practices
Momenta Pharmaceuticals, Inc. (MNTA) To Webcast Presentation At The Canaccord Genuity Growth Conference